Altimmune, Inc.

8-K Regulation FD disclosure; Other events Jul 28, 2026 8-K Other events Jun 16, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Results of operations (earnings release) May 13, 2026 8-K Entered a material agreement Apr 24, 2026 8-K Amended charter or bylaws; Shareholder vote results Apr 16, 2026 10-K Fiscal year ended 2025-12-31 Mar 6, 2026 8-K Results of operations (earnings release) Mar 5, 2026 8-K Other events Feb 3, 2026 8-K Entered a material agreement Jan 28, 2026 8-K Regulation FD disclosure; Other events Dec 19, 2025 8-K Director or officer change; Regulation FD disclosure Dec 1, 2025 8-K Entered a material agreement; Terminated a material agreement Nov 6, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Entered a material agreement; Results of operations (earnings release); Took on a direct financial obligation Nov 6, 2025 8-K Director or officer change Oct 3, 2025 8-K Shareholder vote results Sep 25, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release) Aug 12, 2025 8-K Regulation FD disclosure; Other events Jun 26, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Entered a material agreement; Results of operations (earnings release); Took on a direct financial obligation; Regulation FD disclosure May 13, 2025 8-K Other events Mar 13, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release); Director or officer change Feb 27, 2025 8-K Director or officer change; Regulation FD disclosure Feb 25, 2025 8-K Other events Dec 11, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Director or officer change; Regulation FD disclosure Nov 12, 2024 8-K Shareholder vote results Sep 26, 2024 8-K Director or officer change Aug 15, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Director or officer change; Regulation FD disclosure Jun 26, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release) May 9, 2024 10-K Fiscal year ended 2023-12-31 Mar 27, 2024 8-K Results of operations (earnings release); Other events Mar 27, 2024 8-K Regulation FD disclosure; Other events Nov 30, 2023